George E Duran

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 2

Top Topics

Tyrosine Kinase

Chemotherapy Induced

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Beygi, George E Duran, Sebastian Fernandez-Pol, Alain H Rook, Youn H Kim, Michael S Khodadoust
Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma. Blood 139 (26) (2022)
George E Duran, Branimir I Sikic
The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance. PloS one 14 (1) (2019)